Hapvida acquires another rival

Hapvida acquires another rival

M&A Regulation Brazil

Brazilian healthcare company Hapvida said it has agreed to buy the smaller rival Grupo América for around BRL376m ($96.7m). Hapvida gave Grupo América an enterprise value of BRL426m, or 5.3 times estimated EBITDA for 2020, but it subtracted BRL50m in debt and "potential contingencies," it said in a statement. Hapvida enters the central-west state of Goiás through the acquisition, following a deal last month to buy São Francisco Saúde for BRL5bn. "The acquisition brings relevant operational sy

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial